Flow Imaging Microscopy for Biopharmaceutical Applications 

Subvisible particles can compromise a biologic's safety, stability, and approval. See how flow imaging microscopy—an orthogonal technique recommended by USP <1788>—counts, sizes, characterizes, and identifies particles across protein, cell, and gene therapy formulations.

What's inside:

  • How FlowCam delivers count, size, morphology, and particle identification for subvisible particles
  • Protein therapeutics: distinguishing aggregates, silicone oil, degraded polysorbate, and glass flakes—with VisualAI for composition ID
  • Gene therapy: detecting aggregation in AAV, lentivirus, retrovirus, and LNP formulations
  • CAR-T and cell therapies: differentiating cells from debris and residual beads, plus label-free viability
  • How FlowCam supports USP <788> and <1788> workflows, with a 21 CFR Part 11 compliance option

Fill out the form on the right to download now!

 

Download Content